Pilot clinical trial: propidium monoazide PCR quantifies reduction of the viable bacterial load after antiseptic preparation of canine oral mucosa
American Journal of Veterinary Research · 2023
DOI: 10.2460/ajvr.23.02.0029 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2023. Verfasst von Alicia K Nye und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Clinical Sciences, School of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX. Hauptthemen laut MEDLINE: Anti-Infective Agents, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVE A pilot clinical study to evaluate the use of propidium monoazide PCR (PMA-PCR) in quantifying a reduction of bacterial load after antiseptic use on the canine oral mucosa and skin, comparison of quantitative PCR (qPCR) to PMA-PCR, and comparison of patterns seen between PCR methods and bacterial culture. ANIMALS Client-owned dogs (n = 10) undergoing general anesthesia and intravenous catheter placement. PROCEDURES The oral mucosa and antebrachial skin of each dog underwent swabs for culture, qPCR, and PMA-PCR before and after antiseptic preparation of each site. Reduction in bacterial load between sampling times was evaluated for each quantification method. RESULTS All testing methods found a significant decrease in bacterial load from oral mucosa after antiseptic preparation (culture P = .0020, qPCR P = .0039, PMA-PCR P = .0039). PMA-PCR had a significantly greater reduction of bacterial load after preparation than qPCR ( P = .0494). Only culture detected a significant reduction after preparation of the skin (culture P = .0039, qPCR P = .3125, PMA-PCR P = .0703). CLINICAL RELEVANCE PMA-PCR was able to quantify a reduction of bacterial load after antiseptic preparation of the high-bacterial load environment, with a pattern similar to that of culture, and was more specific than qPCR for detecting viable bacterial load. The results of this study support the use of PMA-PCR for antiseptic effectiveness studies performed on a high-bacterial load environment, such as canine oral mucosa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Small Animal Clinical Sciences, School of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX.
- Gastrointestinal Laboratory, School of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX.
Zitieren
APA
Nye, A. K., Suchodolski, J., Hong, M. P., Park, S. Y., & Thieman Mankin, K. M. (2023). Pilot clinical trial: propidium monoazide PCR quantifies reduction of the viable bacterial load after antiseptic preparation of canine oral mucosa. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.23.02.0029
Vancouver
Nye AK, Suchodolski J, Hong MP, Park SY, Thieman Mankin KM. Pilot clinical trial: propidium monoazide PCR quantifies reduction of the viable bacterial load after antiseptic preparation of canine oral mucosa. American Journal of Veterinary Research. 2023. doi:10.2460/ajvr.23.02.0029
BibTeX
@article{Nye2023,
author = {Nye, Alicia K and Suchodolski, Jan and Hong, Min-Pyo and Park, So Young and Thieman Mankin, Kelley M},
title = {Pilot clinical trial: propidium monoazide PCR quantifies reduction of the viable bacterial load after antiseptic preparation of canine oral mucosa},
journal = {American Journal of Veterinary Research},
year = {2023},
doi = {10.2460/ajvr.23.02.0029}
}
EUVIMED